Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

December 10, 2019

News Features

Year in Review: Physicians Pick the Biggest News of 2018

TCTMD News Team

December 29, 2018

Top News in Clinical Cardiology: 2018

News Features

Top News in Clinical Cardiology: 2018

Yael L. Maxwell

December 28, 2018

Top News in Policy & Practice: 2018

News Features

Top News in Policy & Practice: 2018

December 28, 2018

Top News in Prevention: 2018

News Features

Top News in Prevention: 2018

Michael O'Riordan

December 28, 2018

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

December 30, 2016

A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity

News Features

A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity

Yael L. Maxwell

October 24, 2016

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

News Features

Advocacy Group Blasts Mobile Cardiovascular Screening Company for ‘Unethical’ Practices

Yael L. Maxwell

June 27, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.